PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells

JOURNAL ARTICLE published 17 November 2017 in npj Breast Cancer

Authors: Koichi Ito | Sun Hee Park | Igor Katsyv | Weijia Zhang | Carmine De Angelis | Rachel Schiff | Hanna Y. Irie

Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2− node positive breast cancer—A National Cancer Database study

JOURNAL ARTICLE published 19 October 2017 in npj Breast Cancer

Authors: Prema P. Peethambaram | Tanya L. Hoskin | Courtney N. Day | Matthew P. Goetz | Elizabeth B. Habermann | Judy C. Boughey

MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women

JOURNAL ARTICLE published 25 August 2022 in npj Breast Cancer

Research funded by U.S. Department of Health & Human Services | NIH | National Cancer Institute (R03CA162207,R01CA183086,R01CA183086,R01CA183086) | Gouvernement du Canada | Canadian Institutes of Health Research (RN312225-376411)

Authors: Jennifer D. Brooks | Rebecca A. G. Christensen | Janice S. Sung | Malcolm C. Pike | Irene Orlow | Jonine L. Bernstein | Elizabeth A. Morris

Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo

JOURNAL ARTICLE published 1 May 2017 in npj Breast Cancer

Authors: Jason J. Zoeller | Roderick T. Bronson | Laura M. Selfors | Gordon B. Mills | Joan S. Brugge

Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast

JOURNAL ARTICLE published 7 September 2020 in npj Breast Cancer

Research funded by U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (1ZIACP010126,1ZIACP010126-23,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126,1ZIACP010126) | U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01 CA196383,U01 CA196383,U01 CA196383)

Authors: Clara Bodelon | Hannah Oh | Andriy Derkach | Joshua N. Sampson | Brian L. Sprague | Pamela Vacek | Donald L. Weaver | Shaoqi Fan | Maya Palakal | Daphne Papathomas | Jackie Xiang | Deesha A. Patel | Laura Linville | Susan E. Clare | Daniel W. Visscher | Carolyn Mies | Stephen M. Hewitt | Louise A. Brinton | Anna Maria V. Storniolo | Chunyan He | Stephen J. Chanock | Montserrat Garcia-Closas | Gretchen L. Gierach | Jonine D. Figueroa

LobSig is a multigene predictor of outcome in invasive lobular carcinoma

JOURNAL ARTICLE published 27 June 2019 in npj Breast Cancer

Research funded by Cancer Council Queensland (APP631585)

Authors: Amy E. McCart Reed | Samir Lal | Jamie R. Kutasovic | Leesa Wockner | Alan Robertson | Xavier M. de Luca | Priyakshi Kalita-de Croft | Andrew J. Dalley | Craig P. Coorey | Luyu Kuo | Kaltin Ferguson | Colleen Niland | Gregory Miller | Julie Johnson | Lynne E. Reid | Renique Males | Jodi M. Saunus | Georgia Chenevix-Trench | Lachlan Coin | Sunil R. Lakhani | Peter T. Simpson

Prognostic gene expression assays in breast cancer: are two better than one?

JOURNAL ARTICLE published 22 May 2018 in npj Breast Cancer

Authors: Joseph A. Sparano

PARP inhibition in breast cancer: progress made and future hopes

JOURNAL ARTICLE published 8 April 2022 in npj Breast Cancer

Authors: Nadine Tung | Judy E. Garber

PI3K/AKT signaling activates HIF1α to modulate the biological effects of invasive breast cancer with microcalcification

JOURNAL ARTICLE published 13 November 2023 in npj Breast Cancer

Research funded by National Natural Science Foundation of China (21834002,21834002,21834002,21834002,21834002,21834002,21834002)

Authors: Yao Tian | Lu Zhao | Zhengwei Gui | Shiyang Liu | Chenguang Liu | Tianyao Yu | Lin Zhang

Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic review

JOURNAL ARTICLE published 30 March 2016 in npj Breast Cancer

Authors: Karen A Cadoo | Devika Gajria | Emily Suh | Sujata Patil | Maria Theodoulou | Larry Norton | Clifford A Hudis | Tiffany A Traina

Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy

JOURNAL ARTICLE published 29 July 2022 in npj Breast Cancer

Authors: Romy Aarnoutse | Janine Ziemons | Lars E. Hillege | Judith de Vos-Geelen | Maaike de Boer | Saskia M. P. Bisschop | Birgit E. P. J. Vriens | Jeroen Vincent | Agnes J. van de Wouw | Giang N. Le | Koen Venema | Sander S. Rensen | John Penders | Marjolein L. Smidt

Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer

JOURNAL ARTICLE published 13 August 2020 in npj Breast Cancer

Authors: Olga Kantor | Stephanie Wong | Anna Weiss | Otto Metzger | Elizabeth A. Mittendorf | Tari A. King

Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6

JOURNAL ARTICLE published 8 March 2022 in npj Breast Cancer

Authors: Andrew W. Chung | Anthony J. Kozielski | Wei Qian | Jianying Zhou | Ann C. Anselme | Alfred A. Chan | Ping-Ying Pan | Delphine J. Lee | Jenny C. Chang

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer

JOURNAL ARTICLE published 28 May 2021 in npj Breast Cancer

Research funded by Israel Cancer Association USA (2017-0140) | Israel Cancer Research Fund (16-116-CRCDA)

Authors: Tamar Zahavi | Mali Salmon-Divon | Roberto Salgado | Michael Elkin | Esther Hermano | Ariel M. Rubinstein | Prudence A. Francis | Angelo Di Leo | Giuseppe Viale | Evandro de Azambuja | Lieveke Ameye | Christos Sotiriou | Asher Salmon | Nataly Kravchenko-Balasha | Amir Sonnenblick

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial

JOURNAL ARTICLE published 9 September 2023 in npj Breast Cancer

Authors: Sonja Vliek | Florentine S. Hilbers | Erik van Werkhoven | Ingrid Mandjes | Rob Kessels | Sieta Kleiterp | Esther H. Lips | Lennart Mulder | Mutamba T. Kayembe | Claudette E. Loo | Nicola S. Russell | Marie-Jeanne T. F. D. Vrancken Peeters | Marjo J. Holtkamp | Margaret Schot | Joke W. Baars | Aafke H. Honkoop | Annelie J. E. Vulink | Alex L. T. Imholz | Suzan Vrijaldenhoven | Franchette W. P. J. van den Berkmortel | Jetske M. Meerum Terwogt | Jolanda G. Schrama | Philomeen Kuijer | Judith R. Kroep | Annemieke van der Padt-Pruijsten | Jelle Wesseling | Gabe S. Sonke | Kenneth G. A. Gilhuijs | Agnes Jager | Petra Nederlof | Sabine C. Linn

Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer

JOURNAL ARTICLE published 15 November 2019 in npj Breast Cancer

Research funded by Breast Cancer Research Foundation (BCRF-18-040,BCRF-18-040,BCRF-18-040)

Authors: Ben P. Haynes | Ophira Ginsburg | Qiong Gao | Elizabeth Folkerd | Maria Afentakis | Richard Buus | Le Hong Quang | Pham Thi Han | Pham Hong Khoa | Nguyen Van Dinh | Ta Van To | Mark Clemons | Chris Holcombe | Caroline Osborne | Abigail Evans | Anthony Skene | Mark Sibbering | Clare Rogers | Siobhan Laws | Lubna Noor | Ian E. Smith | Mitch Dowsett

Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?

JOURNAL ARTICLE published 25 October 2021 in npj Breast Cancer

Authors: Mary Kathryn Abel | Michelle E. Melisko | Hope S. Rugo | A. Jo Chien | Italia Diaz | Julia K. Levine | Ann Griffin | Joseph McGuire | Laura J. Esserman | Hala T. Borno | Rita A. Mukhtar

Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer

JOURNAL ARTICLE published 1 March 2021 in npj Breast Cancer

Authors: Della Makower | Juan Lin | Xiaonan Xue | Joseph A. Sparano

Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy

JOURNAL ARTICLE published 20 January 2016 in npj Breast Cancer

Authors: Carly Bess Williams | Elizabeth S Yeh | Adam C Soloff

The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment

JOURNAL ARTICLE published 1 June 2021 in npj Breast Cancer

Authors: Mads G. Jørgensen | Navid M. Toyserkani | Frederik G. Hansen | Anette Bygum | Jens A. Sørensen